Top Banner
P020A Lecture 5 -
128

P020A

Feb 24, 2016

Download

Documents

blithe

P020A . Lecture 5 - . Course Objective #30. Identify the causative agent and the effects on the fetus in the following maternal infections: Rubella Toxoplasmosis Syphilis Cytomegalovirus. Development. Cephalocaudal Proximal-distal . Rubella. AKA German Measles. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: P020A

P020A

Lecture 5 -

Page 2: P020A

Course Objective #30

• Identify the causative agent and the effects on the fetus in the following maternal infections:– Rubella– Toxoplasmosis– Syphilis– Cytomegalovirus

Page 3: P020A

Development

• Cephalocaudal• Proximal-distal

Page 4: P020A

Rubella• AKA– German Measles

Page 5: P020A

Congenital Rubella Syndrome

• AKA – “Blueberry Muffin Syndrome”

• 1st trimester – 85% affected

• After 20 weeks– Defects rare

Page 6: P020A

Congenital Rubella SyndromeEtiology

• Intrauterine Infection• Critical Time period – 1st trimester

Page 7: P020A

Congenital Rubella SyndromeFYI

• 1941 Australian epidemic– 78 infants w/CRS

• 1964-65 US epidemic – 20.5 M cases of Rubella – 20,000 infants w/CRS

Page 8: P020A

Congenital Rubella SyndromeS&S

• Varied • ID – Normal – severe

• Sensory defects– Deaf*– Blind

Page 9: P020A

Congenital Rubella Syndrome

• S&S– Cardiac defects– Microcephaly– Bone abnormalities– Purpura

Page 10: P020A

Congenital Rubella Syndrome• Treatment• Prevention –Rubella vaccine licensed in

1969•MMR

–2005 Rubella eradicated in US

Page 11: P020A

Rubella Virus Eliminated in the United States

• Washington Post --Monday, March 21, 2005• The invisible "chain of transmission" of rubella virus

has been broken in the United States. With it disappears a disease that a little more than a generation ago struck fear in the heart of every pregnant woman.

• Fewer than 10 people a year in this country now contract the infection known popularly as German measles. Since 2002, all cases have been traceable to foreigners who carried the virus in from abroad.

Page 12: P020A

Congenital Toxoplasmosis

• Toxoplasmosis –Protozoa Parasite–“Transplacental spread” Congenital

Toxoplasmosis

Page 13: P020A

Congenital Toxoplasmosis

• Etiology–Raw, undercooked meat, –Cat feces, –Non-pasteurized milk

Page 14: P020A

Congenital Toxoplasmosis

• Incidence–1:10,000 births

• Prognosis–Many die in 1st month

Page 15: P020A

Congenital Toxoplasmosis

• S&S–Vary widely depending on period of infection

Page 16: P020A

Congenital Toxoplasmosis

• S&S• Triad –Hydrocephalus–Intracranial calcification–Chorioretinitis

Page 17: P020A

Congenital Toxoplasmosis

• Severe ID• Blindness• Epilepsy• Low birth weight• Hepatosplenomegaly –Jaundice

Page 18: P020A

Congenital Toxoplasmosis

•Tx–Antibiotics

Page 19: P020A

Congenital Toxoplasmosis

•Dx–Amniocentesis–Ultrasound

Page 20: P020A

Congenital Syphilis

• Etiology: –Spirochete bacterium –Bacteria!!!!

Page 21: P020A

Congenital Syphilis

•Mom infant –during pregnancy or birth

• Fetus vulnerable –after 18 weeks

Page 22: P020A

Congenital Syphilis

• Incidence–1:100,000 live births (CDC,

2002)• @ 50% die in utero or shortly

before or after birth

Page 23: P020A

Congenital SyphilisS&S

Early stage • Failure to thrive,• Nasal discharge• Blistery rash• No nasal bridge

Page 24: P020A

Congenital Syphilis

• Late stage• Hutchinson’s triad–Hutchinson’s teeth–Keratitis–Deaf

Page 25: P020A

Congenital Syphilis

• Late stage• ID• Bone pain• Vision/hearing loss

Page 26: P020A

Congenital Syphilis

• Treatment–Mom•Prenatal care •Antibiotics

–Delivery•Cesarean

Page 27: P020A

Congenital Cytomegalovirus• Herpes-like infection

Page 28: P020A

Congenital Cytomegalovirus

• Etiology–Transplacental spread

Page 29: P020A

Congenital CytomegalovirusFYI

• Mom may be asymptomatic• 1% all newborns test positive for CMV• 95% asymptomatic• 5% congenitally affected

Page 30: P020A

Congenital cytomegalovirus

• The mother's illness may not have symptoms, so she may be unaware that she has CMV.

Page 31: P020A

Congenital CytomegalovirusS&S

• Inflammation of the retina• Hepatosplenomegaly – Jaundice

• Low birth weight• Petechiae• Seizures• Microcephaly

Page 32: P020A

Congenital CytomegalovirusDx Tests

• Antibody titer against CMV • Bilirubin level • TORCH screen

Page 33: P020A

Congenital CytomegalovirusTx

• Focus on specific problems

Page 34: P020A

Congenital CytomegavirusPrognosis

• Up to 90% of infants who have symptoms of their infection at birth will have neurologic abnormalities later in life. Only about 5 - 10% of infants without symptoms will have these problems.

Page 35: P020A

Congenital CytomegalovirusFYI

-neonatal death is common

Page 36: P020A

Congenital CytomegalovirusPrevention

• CMV is almost everywhere• Wash hands p touching diapers• ⌀ kiss kids < 6 yrs• ⌀ share food c kids• PG ⌀ work with < 2 1/2

Page 37: P020A

Objective #31

• Describe the cause, sequence of events, pathology and preventative factors of erythroblastosis fetalis.

Page 38: P020A

Course Objective #32

• Describe the relationship of the Rh factor disorders and kernicterus

Page 39: P020A

Erythroblastosis Fetalis

• What is erythroblastosis fetalis?

Page 40: P020A

Erythroblastosis Fetalis

• Hemolytic disease–ABO incompatibility–Rh incompatibility

Page 41: P020A

Erythroblastosis Fetalis

• Neonate red blood cell destruction

Page 42: P020A

Erythroblastosis FetalisS&S

• Anemia• Hepatoslenomegaly• Jaundice• Hydrops

Page 43: P020A

Erythroblastosis FetalisDx test

• Complete blood count and immature red blood cell (reticulocyte) count

• Bilirubin level• Blood typing

Page 44: P020A

Erythroblastosis FetalisTreatment

• Phototherapy: –bilirubin breaks down when

exposed to UV light•Blood transfusion

Page 45: P020A

Maternal-Fetal Blood Incompatibilities

-Rh Incompatibility

-ABO Incompatibility

Page 46: P020A

ABO Incompatibility

• Etiology–Mom blood type•O

–Fetus blood type•A •B

Page 47: P020A

ABO Incompatibility

S&S•Mild–Anemia–Jaundice

Page 48: P020A

ABO Compatibility

• Severe –Kernicterus •Brain damage d/t h bilirubin levels

Page 49: P020A

ABO Incompatibility

Treatment• Phototherapy

Page 50: P020A

Rh incompatibility

• Mom blood type – Rh-

• Fetus blood type – Rh+

Page 51: P020A

Rh incompatibility

• Mom develops antibodies to Rh+• Immune response • Destruction of RBC of fetus

Page 52: P020A

Rh incompatibility

•Anemia•h bilirubin

Page 53: P020A

Rh incompatibility

• Neonates Liver can’t adequately metabolizes bilirubin • Kernicterus

Page 54: P020A

Rh incompatibilityS&S - Uterio

• Polyhydramnios• h bilirubin

Page 55: P020A

Rh incompatibilityS&S - neonate

•Mischarge• Jaundice•Hypotonia•Lethargy

Page 56: P020A

Rh incompatibilityTreatment (neonate)

• Phototherapy• Blood transfusions

Page 57: P020A

Rh incompatibilityTreatment

• RhoGAM

Page 58: P020A

Rh incompatibility

• Full recovery is expected for mild Rh incompatibility.

Page 59: P020A

Rh incompatibilityPrevention

• RhoGAM• Prevents development of antibodies

against Rh+ blood• Schedule–2nd trimester –Post deliver

Page 60: P020A

Kernicterus• Neonatal brain damage due to destruction of

RBC in utero • h bilirubin crosses “blood-brain barrier” • Brain damage

Page 61: P020A

KernicterusEtiology

• Rh incompatibility • Drugs• liver anomalies• Blood incompatibilities

Page 62: P020A

KernicterusS&S

• Varied S&S• Characteristic: jaundice

Page 63: P020A

KernicterusS&S

• Choreoathetosis • Spastic paralysis• Hypotonia• Anemia• Hypoxia

Page 64: P020A

Course Objective #33

• Describe the fetal effects from maternal use of the following teratogens– Narcotics– Marijuana– Alcohol– Thalidomide– Anti-convulsants– Tobacco

Page 65: P020A

Drugs and Alcohol(teratogens-potential to produce mutation)

Teratogenspotential to produce mutation

Page 66: P020A

NarcoticsExamples:• Heroin• Methadone

Page 67: P020A

Narcotics

Effect• Retarded fetal growth/low birth weight • Addicted

Page 68: P020A

Narcotic Addicted Neonate

• Withdrawal S&S– Begin @ day 4 four– Last a few weeks :

Page 69: P020A

Narcotic Addicted Neonate

S&S - Withdrawal– Tremors seizures– i swallow– Diarrhea– Tachypnea– h temp diaphoresis

Page 70: P020A

Narcotic

S&S up to 6 mo. • Hyperirritability • Hyperreflexia• Tremulousness• i social responsiveness

Page 71: P020A

Narcotic

S&S up to 6 mo.

• No evidence of congenital abnormalities

Page 72: P020A

Cocaine• Drug type–Stimulant

• Action:–constricts blood vessels –i circulation to brain

Page 73: P020A

Cocaine• Transmission–Transplacental –Lactation

Page 74: P020A

Cocaine

• Effects: –MOM• increased risk of abruptio

placentae

Page 75: P020A

Cocaine

• Effects: • Baby–low birth wt–small –premature

Page 76: P020A

Cocaine

• Withdrawal begins –when cord is cut

Page 77: P020A

Cocaine

• Withdrawal S&S–Tachycardia–Tremors–Hyperirritability–feeding problems–sleep problems –h risk of seizures (lifelong)

Page 78: P020A

CocaineFYI

-by 2 years, 2/3 are developing normally -other 1/3 show difficulty maintaining attention,

interacting with other children, adapting to change

Page 79: P020A

Marijuana• Hallucinogen

Page 80: P020A

Marijuana

• i muscle mass • Tremors• h startle reflex

Page 81: P020A

Alcohol• Type of drug– Depressant

Page 82: P020A

Alcohol• Effects– variable

Page 83: P020A

AlcoholFetal Alcohol Effects

• Less severe

Fetal Alcohol Syndrome

• Severe

Page 84: P020A

Fetal Alcohol Syndrome

Full-blown

Page 85: P020A

Alcohol

•Alcohol • i umbilical blood

circulation•Hypoxia

Page 86: P020A

FAS Characteristics

• i palpebral fissures• Flat nose bridge &

philtrum• Thin upper lips

Page 87: P020A

FAS Characteristics

•Microcephaly• Delayed development• ID• Hyperactivity

Page 88: P020A

FAS: Infancy

• Small w/ Stunted growth • Microcephaly• Tremor• Irritable• i sucking reflex• Failure to thrive

Page 89: P020A

FAS: Early Childhood

• Speech & motor delayed• Short• Hyperactivity• FAS face diminish

Page 90: P020A

FAS: School Age

• ID–2/3 moderate – low/average IQ

• Behavior problems • Hyperactivity & ADD

Page 91: P020A

FAS: Young Adulthood

• Cognitive problems–Memory–Orientation to time, space, – Judgment

• Vulnerable to – alcoholism

Page 92: P020A

FAS: Treatment

• Symptomatic• Prevention

Page 93: P020A

Rx: Thalidomide• Action–Anti-emetic

• Critical time period–First trimester

Page 94: P020A

Thalidomide

Effect on fetus• Limb deformities• Normal intelligence

Page 95: P020A

Anticonvulsants• Rx: Dilantin (Phenytoin)• Effect: –4-7% cleft lip / palate

Page 96: P020A

Anticonvulsants

• Monitor lab values• Risk to benefit • Poly-pharmacy h risk

Page 97: P020A

Nicotine• Type of drug–Stimulant

• Effects–i birth weight

• Critical time period–3rd trimester

Page 98: P020A

Maternal-Fetal Irradiation

AKA: –X-ray

• Effects–Microcephaly

Page 99: P020A

Radiation

• Critical time period–1st & 2nd trimester

Page 100: P020A

Course Objective #34

State the various cause and results to the infant of perinatal asphyxia.

Page 101: P020A

Asphyxia

• Brain injury during delivery caused by prolonged deprivation of fetal O2• Maybe permanent CNS effects

Page 102: P020A

Perinatal

Toxemia / EclampsiaPrematurity Physical TraumaInfection

Page 103: P020A

Toxemia

• Triad S&S (Maternal)–HTN–Edema–Proteinuria

Page 104: P020A

Toxemia

• h B/P • i circulation to the uterus • i O2

Page 105: P020A

Toxemia

• Placenta degenerates • Critical period–3rd trimester

Page 106: P020A

Pre-Eclampsia

• + for 3 S&S of toxemia • Most common in –Primigravida

Page 107: P020A

Eclampsia

• 3 S&S + seizure• h risk –Maternal death –Fetal loss

Page 108: P020A

Complications of Toxemia

• Abruptio placentae• Hemolysis• Cerebral hemorrhage• Pulmonary edema• Renal failure

Page 109: P020A

Toxemia Treatment

• Termination of pregnancy resolves all symptoms!

Page 110: P020A

Prematurity

• Birth weight < 5.5 lbs. OR • Gestational age < 38 wks.

Page 111: P020A

Prematurity

Moms without prenatal care are 3 times more likely to birth early

Page 112: P020A

Prematurity: Risk Factors

• Lack prenatal care• i $• Smoking• Maternal age –< 18–>35

Page 113: P020A

Vulnerabilities of Premature Infants

1. Death2. ID3. i temp regulation

Page 114: P020A

Vulnerabilities of Premature Infants

4. i sucking/swallowing 5. immature liver 6. O2 deprivation

Page 115: P020A

Vulnerabilities of Premature Infants

7. Vision problems8. Cerebral hemorrhage 9. Infection

Page 116: P020A

Infection

Herpes Simplex

Page 117: P020A

Herpes Simplex

• 80% result in death or serious problems–ID–Blind

Page 118: P020A

Herpes Simplex

•Causative agent: –Herpes simplex virus 2 (HSV-2) •Genital

•Prevention–C-section

Page 119: P020A

PostnatalInfectionsCerebral TraumaCerebrovascular AccidentBrain Tumors Poison and Environmental ToxinsMalnutritionCerebral PalsyEpilepsy

Page 120: P020A

Physical Trauma

• Leading cause of death infant–MVA

Page 121: P020A

Physical Trauma

• 2nd leading cause of death - < 2yrs –Abuse

Page 122: P020A

Course Objective #35

• State the symptoms seen in a child suffering from: A. Lead poisoning B. Mercury poisoning

Page 123: P020A

Poisons and Environmental Toxins: Lead

• Source– Paints– Water

Page 124: P020A

Poisons and Environmental Toxins

• Severe effect:• Lead encephalitis • S&S–Stupor – coma–Seizures

Page 125: P020A

Poisons and Environmental Toxins: Lead

• Effect –i IQ –i attention span,–personality changes

Page 126: P020A

Poisons and Environmental Toxins: Lead

• Treatment–Diet –i fat–h iron, Ca, Vitamin C

Page 127: P020A

Poisons and Environmental Toxins

Mercury • Food –TUNA

Page 128: P020A

Poisons and Environmental ToxinsMercury: S&S

• Paresthesia• Vision impairment• Motor problems• Hearing• ID